1.Progress in research on triptolide.
Ming-xing LIU ; Jing DONG ; Ya-jiang YANG ; Xiang-liang YANG ; Hui-bi XU
China Journal of Chinese Materia Medica 2005;30(3):170-174
To further understand triptolide, this paper has introduced the pharmacology, pharmacokinetics, toxicity, the clinic application and semi-synthesis of triptolide on basis of importance and significant contents of reference which have been consulted in the past twenty years. Presently triptolide and Tripterygium wilfordii have been a hot spot of modernization of Chinese traditional medicine. It is very important to develop a new dosage form of high effect and low toxicity by making use of advanced technology according to its characteristics.
Animals
;
Anti-Inflammatory Agents, Non-Steroidal
;
pharmacology
;
Antineoplastic Agents, Alkylating
;
pharmacology
;
Antispermatogenic Agents
;
pharmacology
;
Diterpenes
;
chemical synthesis
;
isolation & purification
;
pharmacology
;
toxicity
;
Epoxy Compounds
;
Humans
;
Immunosuppressive Agents
;
pharmacology
;
Phenanthrenes
;
isolation & purification
;
pharmacology
;
toxicity
;
Tripterygium
;
chemistry
2.The effect of an antioxidant tea polyphenols on cell apoptosis in rat model of cyclosporine-induced chronic nephrotoxicity.
Shaohua SHI ; Shusen ZHENG ; Changku JIA ; Youfa ZHU ; Haiyang XIE
Chinese Journal of Surgery 2002;40(9):709-712
OBJECTIVETo investigate the effect of tea polyphenols on cell apoptosis in rat model of cyclosporine-induced chronic nephrotoxicity.
METHODSFour groups of animals in rat model of cyclosporine-induced chronic nephrotoxicity were respectively treated by olive oil (n = 6), tea polyphenols (TP, n = 6), cyclosporine A (CsA, n = 8) and TP plus CsA (n = 8). At the end of 28th day of treatment, all animals were sacrificed and blood was analyzed for blood serum creatinine and creatinine clearance, kidney tissue for pathologic analysis. The TUNEL assay, caspase-3 mRNA expression detected by reverse transcription-polymerase chain reaction (RT-PCR) and caspase-3 activity were used for the analysis of cell apoptosis.
RESULTSCsA plus TP ameliorated the CsA-induced decrease of renal function and interstitial fibrosis. There was a significant increase in the number of apoptosis-positive cells in the CsA-vs-CsA plus TP-treated group at four weeks (18.9 +/- 3.3 vs. 7.7 +/- 1.4, P < 0.05). The expression of caspase-3 mRNA and caspase-3 activity of CsA-treated group was significantly higher than that of CsA plus TP-treated group (P < 0.05).
CONCLUSIONThese results indicate that antioxidant tea polyphenols significantly inhibit apoptosis of tubular and interstitial cells in rat model of chronic cyclosporine-induced nephrotoxicity, and suggest that the decrease of cell apoptosis exerted by tea polyphenols may be one of mechanisms to protect renal function and tissue structure.
Animals ; Antioxidants ; pharmacology ; Apoptosis ; drug effects ; Caspase 3 ; Caspases ; genetics ; Cyclosporine ; toxicity ; Flavonoids ; Immunosuppressive Agents ; toxicity ; In Situ Nick-End Labeling ; Kidney ; drug effects ; Male ; Phenols ; pharmacology ; Polymers ; pharmacology ; Polyphenols ; RNA, Messenger ; analysis ; Rats ; Rats, Sprague-Dawley ; Tea
3.-Melanocyte Stimulating Hormone (MSH) decreases cyclosporine A induced apoptosis in cultured human proximal tubular cells.
Sang Kyung JO ; So Young LEE ; Sang Youp HAN ; Dae Ryong CHA ; Won Yong CHO ; Hyoung Kyu KIM ; Nam Hee WON
Journal of Korean Medical Science 2001;16(5):603-609
The pathogenesis of chronic cyclosporine A (CsA) nephrotoxicity has not been elucidated, but apoptosis is thought to play an important role in CsA induced tubular atrophy. Recently Fas-Fas ligand system mediated apoptosis has been frequently reported in many epithelial cells as well as in T lymphocytes. We investigated the ability of CsA to induce apoptosis in cultured human proximal tubular epithelial cells and also the effect of -MSH on them. Fas, Fas ligand, and an intracellular adaptor protein, Fas-associating protein with death domain (FADD) expression, and poly-ADP ribose polymerase (PARP) cleavage were also studied. CsA induced apoptosis in cultured tubular epithelial cells demonstrated by increased number of TUNEL positive cells and it was accompanied by a significant increase in Fas mRNA and Fas ligand protein expressions. FADD and the cleavage product of PARP also increased, indicating the activation of caspase. In -MSH co-treated cells, apoptosis markedly decreased with downregulation of Fas, Fas ligand and FADD expressions and also the cleavage product of PARP. In conclusion, these data suggest that tubular cell apoptosis mediated by Fas system may play a role in tubular atrophy in chronic CsA nephrotoxicity and pretreatment of -MSH may have a some inhibitory effect on CsA induced tubular cell apoptosis.
Antigens, CD95/genetics
;
Apoptosis/*drug effects
;
Carrier Proteins/biosynthesis
;
Caspases/physiology
;
Cells, Cultured
;
Cyclosporine/*toxicity
;
Human
;
Immunosuppressive Agents/*toxicity
;
Kidney Tubules, Proximal/cytology/*drug effects/metabolism
;
Membrane Glycoproteins/biosynthesis
;
NAD+ ADP-Ribosyltransferase/metabolism
;
RNA, Messenger/analysis
;
alpha-MSH/*pharmacology
4.Comparison of Early and Late Conversion of Sirolimus in Experimental Model of Chronic Cyclosporine Nephropathy.
Jin Young KIM ; Jung Yeon GHEE ; Sun Woo LIM ; Shang Guo PIAO ; Byung Ha CHUNG ; Hye Eun YOON ; Hyeon Seok HWANG ; Bum Soon CHOI ; Jin KIM ; Chul Woo YANG
Journal of Korean Medical Science 2012;27(2):160-169
Sirolimus (SRL) is a promising drug for replacing calcineurin inhibitors. We performed this study to determine the optimal time of conversion from cyclosporine (CsA) to SRL in an experimental model of chronic CsA nephropathy. Three separate studies were performed. In the first study, SRL was given to rats with or without CsA for 4 weeks. In the second study, rats were treated initially with CsA for 1 week, and then switched to SRL (early conversion). In the third study, CsA was given for 4 weeks and then replaced by SRL for 4 weeks treatment of CsA (late conversion). The influence of SRL on CsA-induced renal injury was evaluated by assessing renal function, histopathology (interstitial inflammation and fibrosis), and apoptotic cell death. Combined CsA and SRL treatment significantly impaired renal function, increased apoptosis, and interstitial fibrosis and inflammation compared with CsA or SRL treatment alone. Early conversion to SRL did not change renal function, histopathology, or apoptosis compared with early CsA withdrawal. By contrast, late conversion to SRL significantly aggravated these parameters compared with late CsA withdrawal. In conclusion, early conversion from CsA to SRL is effective in preventing CsA-induced renal injury in a setting of CsA-induced renal injury.
Animals
;
Apoptosis/drug effects
;
Chronic Disease
;
Cyclosporine/*toxicity
;
Immunosuppressive Agents/*pharmacology
;
Intestines/drug effects/pathology
;
Kidney Diseases/chemically induced/*pathology
;
Male
;
Models, Animal
;
Rats
;
Rats, Sprague-Dawley
;
Sirolimus/*pharmacology
5.Cyclosporin A Inhibits Albumin Synthesis in Huh7 Cells.
The Korean Journal of Internal Medicine 2011;26(3):314-319
BACKGROUND/AIMS: Hypoalbuminemia occurs frequently in renal transplant recipients immediately after renal transplantation. We studied the regulation of hepatic albumin synthesis by cyclosporin A (CsA) in Huh7 cells. METHODS: Huh7 cells were incubated with various concentrations of CsA for 4, 8, 16, and 24 hours. Albumin was measured in Huh7 cell-conditioned medium by sandwich enzyme-linked immunosorbent assay and Western blot. Albumin mRNA expression was analyzed by Northern blotting in CsA-treated cells. RESULTS: CsA (10(-7)-10(-4) M) inhibited albumin synthesis in Huh7 cells in a dose- dependent manner. A Western blot analysis for albumin in the conditioned medium released from CsA-treated (10(-7)-10(-5) M) cells also showed significant inhibition of albumin synthesis in a dose-dependent manner. Vehicle (olive oil) did not affect albumin synthesis. In contrast, a Northern blot analysis revealed no inhibition of albumin mRNA expression by CsA at any time point from 1-24 hours, indicating that the inhibition of albumin synthesis occurred at the translational level. CONCLUSIONS: Our results suggest that inhibition of hepatic albumin synthesis by high dose CsA contributes to the hypoalbuminemia in renal transplant recipients.
Blotting, Northern
;
Blotting, Western
;
Carcinoma, Hepatocellular/genetics/*metabolism
;
Cell Line, Tumor
;
Cell Survival/drug effects
;
Culture Media, Conditioned/metabolism
;
Cyclosporine/*pharmacology/toxicity
;
Dose-Response Relationship, Drug
;
Enzyme-Linked Immunosorbent Assay
;
Gene Expression Regulation, Neoplastic/drug effects
;
Humans
;
Hypoalbuminemia/chemically induced/metabolism
;
Immunosuppressive Agents/*pharmacology/toxicity
;
Liver Neoplasms/genetics/*metabolism
;
RNA, Messenger/metabolism
;
Serum Albumin/genetics/*metabolism
;
Time Factors
6.Effects of Thyroxine on Hyperkalemia and Renal Cortical Na(+), K(+) - ATPase Activity Induced by Cyclosporin A.
Chur Woo YOU ; Yong Hoon PARK ; Eun Sil LEE ; Yong Jin KIM ; Son Moon SHIN ; Mi Ok PARK
Journal of Korean Medical Science 2002;17(5):625-632
Cyclosporin A (CsA)-induced hyperkalemia is caused by alterations in transepithelial K(+) secretion resulting from the inhibition of renal tubular Na(+), K(+) -ATPase activity. Thyroxine enhances renal cortical Na(+), K(+) -ATPase activity. This study investigated the effect of thyroxine on CsA-induced hyperkalemia. Sprague-Dawley rats were treated with either CsA, thyroxine, CsA and thyroxine, or olive-oil vehicle. CsA resulted in an increase in BUN and serum K(+), along with a decrease in creatinine clearance, fractional excretion of potassium, and renal cortical Na(+), K(+) -ATPase activity, as compared with oil vehicle administration. Histochemical study showed reduced Na(+), K(+) -ATPase activity in the proximal tubular epithelial cells of the CsA-treated compared with the oil-treated rats. Histologically, isometric intracytoplasmic vacuolation, disruption of the arrangement and swelling of the mitochondria, and a large number of lysosomes in the tubular epithelium were characteristic of the CsA-treated rats. Co-administration of thyroxine prevented CsA-induced hyperkalemia and reduced creatinine clearance, Na(+), K(+) -ATPase activity, and severity of the histologic changes in the renal tubular cells when compared with the CsA-treated rats. Thyroxine increased the fractional excretion of potassium via the preservation of Na(+), K(+) -ATPase activity in the renal tubular cells. Thus, the beneficial effects of thyroxine may be suited to treatment modalities for CsA-induced hyperkalemia.
Animals
;
Cyclosporine/antagonists & inhibitors/*toxicity
;
Hyperkalemia/chemically induced/*drug therapy/metabolism/prevention & control
;
Immunosuppressive Agents/antagonists & inhibitors/*toxicity
;
Kidney Cortex/*drug effects/*enzymology/pathology
;
Male
;
Microsomes/enzymology
;
Potassium/blood/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Sodium-Potassium-Exchanging ATPase/*metabolism
;
Thyroxine/*pharmacology
7.Thalidomide Accelerates the Degradation of Extracellular Matrix in Rat Hepatic Cirrhosis via Down-Regulation of Transforming Growth Factor-beta1.
Peng LV ; Qingshun MENG ; Jie LIU ; Chuanfang WANG
Yonsei Medical Journal 2015;56(6):1572-1581
PURPOSE: The degradation of the extracellular matrix has been shown to play an important role in the treatment of hepatic cirrhosis. In this study, the effect of thalidomide on the degradation of extracellular matrix was evaluated in a rat model of hepatic cirrhosis. MATERIALS AND METHODS: Cirrhosis was induced in Wistar rats by intraperitoneal injection of carbon tetrachloride (CCl4) three times weekly for 8 weeks. Then CCl4 was discontinued and thalidomide (100 mg/kg) or its vehicle was administered daily by gavage for 6 weeks. Serum hyaluronic acid, laminin, procollagen type III, and collagen type IV were examined by using a radioimmunoassay. Matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and alpha-smooth muscle actin (alpha-SMA) protein in the liver, transforming growth factor beta1 (TGF-beta1) protein in cytoplasm by using immunohistochemistry and Western blot analysis, and MMP-13, TIMP-1, and TGF-beta1 mRNA levels in the liver were studied using reverse transcriptase polymerase chain reaction. RESULTS: Liver histopathology was significantly better in rats given thalidomide than in the untreated model group. The levels of TIMP-1 and TGF-beta1 mRNA and protein expressions were decreased significantly and MMP-13 mRNA and protein in the liver were significantly elevated in the thalidomide-treated group. CONCLUSION: Thalidomide may exert its effects on the regulation of MMP-13 and TIMP-1 via inhibition of the TGF-beta1 signaling pathway, which enhances the degradation of extracellular matrix and accelerates the regression of hepatic cirrhosis in rats.
Actins
;
Animals
;
Carbon Tetrachloride/toxicity
;
Collagen Type III/metabolism
;
Down-Regulation
;
Extracellular Matrix/metabolism
;
Immunohistochemistry
;
Immunosuppressive Agents/*pharmacology
;
Liver Cirrhosis, Experimental/chemically induced/*metabolism/pathology/*prevention & control
;
Male
;
RNA, Messenger/analysis/metabolism
;
Rats
;
Rats, Wistar
;
Thalidomide/*pharmacology
;
Tissue Inhibitor of Metalloproteinase-1/biosynthesis/*drug effects
;
Transcription Factor RelA/biosynthesis/drug effects
;
Transforming Growth Factor beta1/biosynthesis/*drug effects
;
Transforming Growth Factors/metabolism
8.Gene expressions of LTC4 synthase homologs in Con A-induced mouse hepatitis and regulative effect of cyclosporine A.
Luo-yang QI ; Kui-fen MA ; Fang-fang LAI
Journal of Zhejiang University. Medical sciences 2007;36(3):241-246
OBJECTIVETo explore the gene expressions of LTC4 synthase homologs in concanavalin A (Con A)-induced mouse hepatitis and regulation role of cyclosporine A (Cs A) treatment.
METHODSMale Balb/c mouse liver injury model was developed by iv injection of Con A (20 mg/kg) and protected by Cs A pretreatment (150 mg/kg) before Con A administration. Blood samples were collected at indicated times after Con A treatment with or without Cs A pretreatment. Liver damage was assessed by serum transaminase ALT and AST measurement and histological evaluation. Meantime, three LTC4 synthase homolog gene expressions were determined by RT-PCR.
RESULTSSerum ALT and AST upregulation were accompanied with histological damage at 2 h after Con A administration, and further aggravated at 8 h. mGST2 gene expression increased 1.7 fold at 2 h and 1.9 fold at 8 h, while the expression of LTC4 S and mGST3 changed little. Pretreatment with Cs A prevented mouse liver from injury by Con A and partly inhibited the mGST2 gene expression upregulation.
CONCLUSIONSAdministration of Con A in mouse lead to a significant increase of mGST2 gene expression without any significant effect on LTC4 S and mGST3 mRNA levels. Cs A pretreatment results in protection of liver damage, whereas fails to fully inhibit the increase of mGST2 gene expression.
Alanine Transaminase ; blood ; Animals ; Aspartate Aminotransferases ; blood ; Chemical and Drug Induced Liver Injury ; enzymology ; etiology ; prevention & control ; Concanavalin A ; administration & dosage ; toxicity ; Cyclosporine ; pharmacology ; Gene Expression Regulation, Enzymologic ; genetics ; Glutathione Transferase ; genetics ; Hepatitis, Animal ; chemically induced ; enzymology ; prevention & control ; Immunosuppressive Agents ; pharmacology ; Injections, Intravenous ; Isoenzymes ; genetics ; Male ; Mice ; Mice, Inbred BALB C ; Reverse Transcriptase Polymerase Chain Reaction
9.Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.
Jun-Peng GAO ; Shan SUN ; Wen-Wei LI ; Yi-Ping CHEN ; Ding-Fang CAI
Neuroscience Bulletin 2008;24(3):133-142
OBJECTIVENeuroinflammation with microglial activation has been implicated to have a strong association with the progressive dopaminergic neuronal loss in Parkinson's disease (PD). The present study was undertaken to evaluate the activation profile of microglia in 1-methyl-4-phenyl pyridinium (MPP+)-induced hemiparkinsonian rats. Triptolide, a potent immunosuppressant and microglia inhibitor, was then examined for its efficacy in protecting dopaminergic neurons from injury and ameliorating behavioral disabilities induced by MPP+.
METHODSThe rat model of PD was established by intranigral microinjection of MPP+. At baseline and on day 1, 3, 7, 14, 21 following MPP+ injection, the degree of microglial activation was examined by detecting the immunodensity of OX-42 (microglia marker) in the substantia nigra (SN). The number of viable dopaminergic neurons was determined by measuring tyrosine hydroxylase (TH) positive neurons in the SN. Behavioral performances were evaluated by counting the number of rotations induced by apomorphine, calculating scores of forelimb akinesia and vibrissae-elicited forelimb placing asymmetry.
RESULTSIntranigral injection of MPP+ resulted in robust activation of microglia, progressive depletion of dopaminergic neurons, and ongoing aggravation of behavioral disabilities in rats. Triptolide significantly inhibited microglial activation, partially prevented dopaminergic cells from death and improved behavioral performances.
CONCLUSIONThese data demonstrated for the first time a neuroprotective effect of triptolide on dopaminergic neurons in MPP+-induced hemiparkinsonian rats. The protective effect of triptolide may, at least partially, be related to the inhibition of MPP+-induced microglial activation. Our results lend strong support to the use of immunosuppressive agents in the management of PD.
1-Methyl-4-phenylpyridinium ; antagonists & inhibitors ; toxicity ; Animals ; Biomarkers ; metabolism ; CD11b Antigen ; analysis ; metabolism ; Cell Count ; Cell Survival ; drug effects ; physiology ; Disability Evaluation ; Diterpenes ; pharmacology ; therapeutic use ; Dopamine ; metabolism ; Encephalitis ; drug therapy ; immunology ; prevention & control ; Epoxy Compounds ; pharmacology ; therapeutic use ; Gliosis ; drug therapy ; immunology ; prevention & control ; Herbicides ; antagonists & inhibitors ; toxicity ; Immunosuppression ; methods ; Immunosuppressive Agents ; pharmacology ; therapeutic use ; Male ; Microglia ; drug effects ; immunology ; Neurons ; drug effects ; immunology ; pathology ; Parkinsonian Disorders ; drug therapy ; immunology ; physiopathology ; Phenanthrenes ; pharmacology ; therapeutic use ; Rats ; Rats, Sprague-Dawley ; Substantia Nigra ; drug effects ; immunology ; physiopathology ; Treatment Outcome ; Tyrosine 3-Monooxygenase ; analysis ; metabolism